Published in J Bone Miner Res on January 01, 2002
Detection of functional haematopoietic stem cell niche using real-time imaging. Nature (2008) 4.06
Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One (2008) 2.96
Retracted Osteolineage niche cells initiate hematopoietic stem cell mobilization. Blood (2008) 2.84
Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell (2012) 2.36
Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell (2015) 2.29
Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone. J Gerontol A Biol Sci Med Sci (2013) 2.12
Identification of differentially expressed genes between osteoblasts and osteocytes. Bone (2009) 1.97
BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development (2008) 1.86
The osteocyte: an endocrine cell ... and more. Endocr Rev (2013) 1.84
Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology (2008) 1.78
The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol (2004) 1.77
Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. Blood (2011) 1.76
Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med (2011) 1.75
Analysis of αSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing. J Bone Miner Res (2014) 1.66
Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone (2008) 1.59
Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res (2008) 1.54
Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development. Blood (2015) 1.53
Notch and the skeleton. Mol Cell Biol (2009) 1.49
Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone (2008) 1.48
In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells (2012) 1.44
Dynamics of the transition from osteoblast to osteocyte. Ann N Y Acad Sci (2010) 1.37
Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood (2005) 1.32
Osteoblast lineage-specific effects of notch activation in the skeleton. Endocrinology (2012) 1.32
Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat Med (2015) 1.28
Studies of the DMP1 57-kDa functional domain both in vivo and in vitro. Cells Tissues Organs (2008) 1.26
The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs (2008) 1.24
Phenotypic dissection of bone mineral density reveals skeletal site specificity and facilitates the identification of novel loci in the genetic regulation of bone mass attainment. PLoS Genet (2014) 1.21
Reconciling the roles of FAK in osteoblast differentiation, osteoclast remodeling, and bone regeneration. Bone (2007) 1.12
Generation and characterization of Col10a1-mcherry reporter mice. Genesis (2011) 1.12
Genetic mouse models for bone studies--strengths and limitations. Bone (2011) 1.10
In vivo identification of periodontal progenitor cells. J Dent Res (2013) 1.10
In vitro and in vivo approaches to study osteocyte biology. Bone (2012) 1.09
Gsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. J Clin Invest (2011) 1.08
Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arterioscler Thromb Vasc Biol (2013) 1.08
Characterization of stem and progenitor cells in the dental pulp of erupted and unerupted murine molars. Bone (2010) 1.07
Mesenchymal progenitors residing close to the bone surface are functionally distinct from those in the central bone marrow. Bone (2012) 1.07
Generation and characterization of Osterix-Cherry reporter mice. Genesis (2012) 1.05
Notch regulation of bone development and remodeling and related skeletal disorders. Calcif Tissue Int (2011) 1.05
Expression and function of Dlx genes in the osteoblast lineage. Dev Biol (2008) 1.04
GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. J Bone Miner Res (2014) 1.04
Notch signaling components are upregulated during both endochondral and intramembranous bone regeneration. J Orthop Res (2011) 0.98
A BAC-bacterial recombination method to generate physically linked multiple gene reporter DNA constructs. BMC Biotechnol (2009) 0.98
Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function. Infect Immun (2010) 0.97
Identification of cells at early and late stages of polarization during odontoblast differentiation using pOBCol3.6GFP and pOBCol2.3GFP transgenic mice. Bone (2010) 0.97
Inhibition of proprotein convertase SKI-1 blocks transcription of key extracellular matrix genes regulating osteoblastic mineralization. J Biol Chem (2010) 0.96
Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP. Mol Ther (2009) 0.96
Periosteal cells are a major source of soft callus in bone fracture. J Bone Miner Metab (2013) 0.95
The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis (2012) 0.95
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nat Commun (2015) 0.95
Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice. J Bone Miner Res (2012) 0.95
Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem (2009) 0.94
Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes. PLoS One (2012) 0.93
Gdf5 progenitors give rise to fibrocartilage cells that mineralize via hedgehog signaling to form the zonal enthesis. Dev Biol (2015) 0.93
HES1 (hairy and enhancer of split 1) is a determinant of bone mass. J Biol Chem (2010) 0.92
Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartilage (2011) 0.91
Association of specific proteolytic processing of bone sialoprotein and bone acidic glycoprotein-75 with mineralization within biomineralization foci. J Biol Chem (2007) 0.91
Response of knee fibrocartilage to joint destabilization. Osteoarthritis Cartilage (2015) 0.90
The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis. J Immunol (2007) 0.89
A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD). Hum Mol Genet (2010) 0.88
Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover. J Bone Miner Res (2011) 0.87
Isolation and characterization of murine mandibular condylar cartilage cell populations. Cells Tissues Organs (2011) 0.87
Lrp5 is not required for the proliferative response of osteoblasts to strain but regulates proliferation and apoptosis in a cell autonomous manner. PLoS One (2012) 0.86
The effect of fresh bone marrow cells on reconstruction of mouse calvarial defect combined with calvarial osteoprogenitor cells and collagen-apatite scaffold. J Tissue Eng Regen Med (2012) 0.86
Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche. Nat Commun (2016) 0.85
Ectopic expression of SOX9 in osteoblasts alters bone mechanical properties. Calcif Tissue Int (2011) 0.85
Preosteocytes/osteocytes have the potential to dedifferentiate becoming a source of osteoblasts. PLoS One (2013) 0.85
Morphological and proteomic analysis of early stage of osteoblast differentiation in osteoblastic progenitor cells. Exp Cell Res (2010) 0.85
Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol (2010) 0.85
Therapeutic potential of genetically modified adult stem cells for osteopenia. Gene Ther (2009) 0.85
Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model. Int Orthop (2014) 0.84
Signaling pathways implicated in androgen regulation of endocortical bone. Bone (2009) 0.84
Keratocan is expressed by osteoblasts and can modulate osteogenic differentiation. Connect Tissue Res (2011) 0.84
Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties. Bone (2010) 0.84
Cell and matrix response of temporomandibular cartilage to mechanical loading. Osteoarthritis Cartilage (2015) 0.84
Bone tissue engineering with a collagen-hydroxyapatite scaffold and culture expanded bone marrow stromal cells. J Biomed Mater Res B Appl Biomater (2014) 0.84
Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor. Bone (2008) 0.83
Loss of Gsα early in the osteoblast lineage favors adipogenic differentiation of mesenchymal progenitors and committed osteoblast precursors. J Bone Miner Res (2014) 0.83
SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors. Stem Cells (2014) 0.82
Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice. J Biol Chem (2013) 0.82
Inactivation of the androgen receptor in bone-forming cells leads to trabecular bone loss in adult female mice. Bonekey Rep (2013) 0.82
A novel population of cells expressing both hematopoietic and mesenchymal markers is present in the normal adult bone marrow and is augmented in a murine model of marrow fibrosis. Am J Pathol (2011) 0.82
Fixation stability dictates the differentiation pathway of periosteal progenitor cells in fracture repair. J Orthop Res (2015) 0.82
Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation. Bone (2010) 0.81
Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition. Acta Biomater (2014) 0.81
Visualizing osteogenesis in vivo within a cell-scaffold construct for bone tissue engineering using two-photon microscopy. Tissue Eng Part C Methods (2013) 0.81
Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation. J Cell Biochem (2008) 0.80
Lineage tracking of mesenchymal and endothelial progenitors in BMP-induced bone formation. Bone (2015) 0.80
Spatiotemporal Analyses of Osteogenesis and Angiogenesis via Intravital Imaging in Cranial Bone Defect Repair. J Bone Miner Res (2015) 0.79
A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells. Stem Cells Transl Med (2014) 0.79
Activation of Nfatc2 in osteoblasts causes osteopenia. J Cell Physiol (2015) 0.79
Utilization of transgenic models in the evaluation of osteogenic differentiation of embryonic stem cells. Connect Tissue Res (2013) 0.79
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature (2016) 0.78
Gene-expression analysis of cementoblasts and osteoblasts. J Periodontal Res (2015) 0.78
Connective Tissue Growth Factor reporter mice label a subpopulation of mesenchymal progenitor cells that reside in the trabecular bone region. Bone (2014) 0.78
Increased bone mass in mice lacking the adipokine apelin. Endocrinology (2013) 0.78
Role of mathematical modeling in bone fracture healing. Bonekey Rep (2012) 0.78
MBTPS1/SKI-1/S1P proprotein convertase is required for ECM signaling and axial elongation during somitogenesis and vertebral development†. Hum Mol Genet (2015) 0.78
Stage-specific effects of fibroblast growth factor 2 on the differentiation of dental pulp cells. Cells Tissues Organs (2015) 0.77
Osteogenic potential of alpha smooth muscle actin expressing muscle resident progenitor cells. Bone (2015) 0.77
Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology (1986) 4.00
Meiotic gene conversion tract length distribution within the rosy locus of Drosophila melanogaster. Genetics (1994) 3.47
Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res (2001) 3.26
Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology (1998) 2.54
The effect of DNA sequence polymorphisms on intragenic recombination in the rosy locus of Drosophila melanogaster. Genetics (1991) 2.50
Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry (1984) 2.49
Molecular phylogeny and divergence time estimates for major rodent groups: evidence from multiple genes. Mol Biol Evol (2001) 2.42
The underlying bases of gene expression differences in stable transformants of the rosy locus in Drosophila melanogaster. Genetics (1986) 2.12
Molecular analysis of recombination events in Drosophila. Genetics (1989) 1.97
Tissue-specific and pretranslational character of variants of the rosy locus control element in Drosophila melanogaster. Genetics (1984) 1.77
Tracking COL1A1 RNA in osteogenesis imperfecta. splice-defective transcripts initiate transport from the gene but are retained within the SC35 domain. J Cell Biol (2000) 1.74
Neurological abnormalities in familial and sporadic schizophrenia. Brain (1998) 1.68
Cytogenetic analysis of the chromosomal region immediately adjacent to the rosy locus in Drosophila melanogaster. Genetics (1980) 1.66
Genetic transformation of Drosophila melanogaster with an autonomous P element: phenotypic and molecular analyses of long-established transformed lines. Genetics (1987) 1.54
Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci (2001) 1.52
The tissue distribution of T lymphocytes expressing different CD45 polypeptides. Immunology (1989) 1.52
Peptide map comparison of infectious pancreatic necrosis virus-specific polypeptides. J Virol (1977) 1.48
The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker". Int J Neurosci (2005) 1.48
Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells. J Cell Biol (1992) 1.48
Maturation of the reticulocyte in vitro. J Cell Sci (1984) 1.44
An interstitial deletion in the rearranged T-cell receptor gamma chain locus in a case of T-cell acute lymphoblastic leukaemia. Br J Haematol (1993) 1.43
Multiple H4 histone mRNAs of HeLa cells are encoded in different genes. Nature (1982) 1.41
Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1. Proc Natl Acad Sci U S A (1985) 1.38
An immunohistological study of secondary Sjögren's syndrome. Ann Rheum Dis (1984) 1.36
Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res (2001) 1.35
Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res (2001) 1.32
Studies of normal and position-affected expression of rosy region genes in Drosophila melanogaster. Genetics (1986) 1.27
Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology (1999) 1.25
Monoclonal antibodies to human leucocyte antigens in polymyositis and muscular dystrophy. Clin Exp Immunol (1983) 1.24
Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J Bone Miner Res (1994) 1.24
On the identification of the rosy locus DNA in Drosophila melanogaster: intragenic recombination mapping of mutations associated with insertions and deletions. Genetics (1986) 1.23
Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res (1999) 1.22
Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice. Osteoarthritis Cartilage (2007) 1.22
Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest (2001) 1.20
Reduction of target gene expression by a modified U1 snRNA. Mol Cell Biol (2001) 1.18
Analysis of cytoplasmic and nuclear messenger RNA in fibroblasts from patients with type I osteogenesis imperfecta. Methods Enzymol (1987) 1.16
Regulation of histone gene expression in HeLa S3 cells. Cold Spring Harb Symp Quant Biol (1978) 1.16
Regulation of the alpha 1(I) collagen promoter in vascular smooth muscle cells. Comparison with other alpha 1(I) collagen-producing cells in transgenic animals and cultured cells. J Biol Chem (1994) 1.14
Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J Biol Chem (1993) 1.13
Biophysical studies of infectious pancreatic necrosis virus. J Virol (1977) 1.13
Transgenic expression of COL1A1-chloramphenicol acetyltransferase fusion genes in bone: differential utilization of promoter elements in vivo and in cultured cells. Mol Cell Biol (1993) 1.12
Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma. J Pathol (1986) 1.11
Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis (2000) 1.11
Poor prognosis in a case of depression as predicted by the repertory grid. Br J Psychiatry (1971) 1.09
Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology (2001) 1.09
Incomplete disappearance of the processus vaginalis as a cause of ascending testis. J Urol (1997) 1.09
Cell adhesion regulates pro-alpha 1(I) collagen mRNA stability and transcription in mouse fibroblasts. J Biol Chem (1991) 1.09
Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia. Leukemia (1994) 1.08
Genetic modulation of RNA metabolism in Drosophilia. I. Increased rate of ribosomal RNA synthesis. Genetics (1977) 1.08
Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. J Bone Miner Res (2001) 1.08
Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J Biol Chem (1994) 1.07
Right parietal cortex is involved in the perception of sound movement in humans. Nat Neurosci (1998) 1.07
Col1a1-GFP transgene expression in developing incisors. Connect Tissue Res (2002) 1.07
Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J Cell Biochem (2003) 1.06
The mouse mammary tumor virus model in studies of glucocorticoid regulation. Recent Prog Horm Res (1984) 1.06
An in vitro model for mineralization of human osteoblast-like cells on implant materials. Biomaterials (1999) 1.05
Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev Biol (1999) 1.04
Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest (1995) 1.03
A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest (1993) 1.01
Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol (1986) 1.01
Ectopic expression of Msx-2 in posterior limb bud mesoderm impairs limb morphogenesis while inducing BMP-4 expression, inhibiting cell proliferation, and promoting apoptosis. Dev Biol (1998) 1.00
Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes. Lancet (1984) 1.00
Hypophosphatemia and hypercalciuria in small premature infants fed human milk: evidence for inadequate dietary phosphorus. J Pediatr (1984) 1.00
Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology (2002) 1.00
Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors. J Pediatr Surg (2001) 0.99
Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Infect Dis (1987) 0.99
Xanthine dehydrogenase is transported to the Drosophila eye. Genetics (1989) 0.98
Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation (2000) 0.98
Genetic modulation of RNA metabolism in Drosophila. II. Coordinate rate change in 4S, 5S, and poly-A associated RNA synthesis. Genetics (1977) 0.98
Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Cell Prolif (2002) 0.97
The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis (2001) 0.96
Structural and functional organization of a gene in Drosophila melanogaster. Basic Life Sci (1980) 0.95
CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant (2006) 0.94
The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatr Transplant (1999) 0.93
Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J Biol Chem (1996) 0.92
Analysis of microarchitectural changes in a mouse temporomandibular joint osteoarthritis model. Arch Oral Biol (2009) 0.91
Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant Proc (1996) 0.91
Focal vertebral artery dissection causing Brown-Séquard's syndrome. J Neurol Neurosurg Psychiatry (1998) 0.91
Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro. Calcif Tissue Int (2007) 0.91
The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal rat calvariae. Endocrinology (1992) 0.90
Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion. Leukemia (2012) 0.90
Confirmation that the type I collagen gene on chromosome 17 is COL1A1 (alpha 1(I), using a human genomic probe. Ann Hum Genet (1984) 0.90
Multiple forms of H4 histone mRNA in human cells. Proc Natl Acad Sci U S A (1980) 0.90
Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: mediation by cyclic AMP. J Cell Biochem (1991) 0.89
Isolation and characterization of two mRNAs from HeLa S3 cells coding for histone H4. Biochem Biophys Res Commun (1977) 0.89
The molecular weight of human IgD heavy chains. Immunochemistry (1971) 0.89
Epstein-Barr virus-specific T-cell recognition of B-cell transformants expressing different EBNA 2 antigens. Int J Cancer (1987) 0.89
Comparison of image analysis and flow cytometric determination of cellular DNA content. J Clin Pathol (1991) 0.89
RGD-tethered silk substrate stimulates the differentiation of human tendon cells. Clin Orthop Relat Res (2006) 0.88